Psychedelics – News and Features

Spinal cord stimulation is often a last resort for those with intractable chronic pain. A new 10-minute brain scan gives doctors a much-needed biomarker to discuss with patients considering spinal cord stimulation.

A clinical trial found psilocybin treatment for anorexia nervosa led to profound psychological shifts and reduced eating disorder severity in some participants. While 90% rated the experience as transformative, weight recovery remained inconsistent.

A study reveals distinct brain circuits that psychedelics activate to reduce anxiety without causing hallucinations in mice. By isolating the anti-anxiety effects from hallucinogenic responses, researchers hope to develop safer, targeted treatments.

Scientists have pinpointed the binding site for low-dose ketamine on NMDA receptors, explaining its fast-acting effects on depression. Unlike high doses, which block synaptic currents, low doses selectively slow specific receptors.

A new study from ICES and University of Ottawa reveals a 21-fold increase in schizophrenia risk following emergency visits for hallucinogen use. The findings emphasize potential dangers associated with hallucinogen use.

A new study has demonstrated the potential impact of psilocybin-assisted therapy on people with depression, if approved by the FDA.

Research from the Hebrew University published in Molecular Psychiatry shows psilocybin can significantly decrease OCD-like behaviors and tic-like movements in genetically modified mice.

In this article, we explore treatment options for fibromyalgia, what current research can tell us about the disease and what the future of fibromyalgia research could look like.

Research demonstrates that rats given psilocybin exhibit increased optimism and motivation in reward-based tasks. This study provides insights into how psilocybin may address core symptoms of major depression.

A classic psychedelic was found to activate a cell type in the brain that silences other neighboring neurons, a result that provides insight into how such drugs reduce anxiety, according to a new study in mice.